Adjuvant Oxaliplatin Confers Survival Benefit in Colon Ca (CME/CE)
(MedPage Today) — Among community-based colon cancer patients, the addition of oxaliplatin to 5-fluorouracil (5-FU) in the adjuvant treatment setting may offer better survival, according to a retrospective analysis.
Article printed from Gastroenterology Education and CPD for trainees and specialists: https://www.gastrotraining.com